| 摘要 |
<p>The invention relates to pharmaceutical agents on the basis of antiglaucomatous substances and to the use thereof in the treatment of glaucoma. The inventive agents contain lactalbumin hydrolysate or a fraction thereof, thereby allowing much lower doses of the antiglaucomatous agents than conventional agents for achieving a certain antiglaucomatous effect.</p> |
